As we age, the urgency to tackle cognitive decline head-on becomes even greater. New research reveals that simple activities ...

Gate Neurosciences today announced it has entered a definitive agreement to acquire Boost Neuroscience and its leading proprietary platform for human synapse network analysis and synapse-targeted drug ...

CCTV can be an effective form of assistive technology. However, there are ethical and legal issues around using security cameras to keep an eye on someone with dementia that must be taken into account ...

Enter SynPull, a new synaptosome imaging method developed by David Klenerman, John Danial, and colleagues at the University of Cambridge, England. SynPull combines single-molecule pull-down of ...

Early onset Alzheimer’s disease is Alzheimer’s disease that starts before age 65. It’s rare under age 30 and more commonly affects people ages 50 and over. Early detection and treatment can ...

Introduction The European Prevention of Alzheimer’s Dementia (EPAD) project is funded initially by the Innovative Medicines Initiative and has been established to overcome the major hurdles hampering ...

With expertise in research, fundraising, policy and more, our staff are dedicated to making breakthroughs possible. Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined ...

Understand the roles required to perform common tasks in Azure Synapse Understand which Synapse RBAC (role-based access control) roles or Azure RBAC roles you need to get work done in Synapse Studio.

Alzheimer’s can cause distressing behaviors for both the person and caregivers. While not everyone with the condition will become aggressive, it’s important to know how to manage these ...

Languages: English. Taking too long to enter the phase of sleep in which we dream may be an early sign of Alzheimer's disease. This is the conclusion of an international team of researchers who ...

Scientists have recently shown that both the quality and the amount of sleep we get may influence our risk of developing Alzheimer’s disease. Now, a study suggests that people who take significantly ...